| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |